Gagner, Michel http://orcid.org/0000-0001-6068-0333
Cadiere, Guy-Bernard
Sanchez-Pernaute, Andres
Abuladze, David
Krinke, Todd
Buchwald, J. N.
Van Sante, Nathalie
Van Gossum, Marc
Dziakova, Jana
Koiava, Levan
Odovic, Maja
Poras, Mathilde
Almutlaq, Lamees
Torres, Antonio J.
Article History
Received: 1 April 2023
Accepted: 8 May 2023
First Online: 22 May 2023
Declarations
:
: Michel Gagner is a consultant with stock options in GT Metabolic Solutions, and is a consultant for Medtronic, Inc. and Lexington Medical, Inc. with stock options in Lexington Medical, Inc. Guy-Bernard Cadière is a consultant for GT Metabolic Solutions and member of the scientific advisory board without remuneration. Andres Sanchez-Pernaute is a consultant and received fees from Novo Nordisk, Medtronic, Johnson & Johnson, and Gore Medical. David Abuladze is a consultant for GT Metabolic Solutions without remuneration. Todd Krinke is an employee with GT patents and stock options. Jane Buchwald is a GT consultant with GT stock options; she received grants from Ethicon, Inc., M.I.D., Society of Bariatric and Metabolic Surgeons of Kazakhstan, Medical Faculty of Mannheim, Holy Family Hospital, Israel, and the American College of Surgeons. Nathalie Van Sante was an employee of GT Metabolic Solutions, Inc. during the study and drafting of the manuscript. Lamees Almutlaq holds stock options in GT Metabolic Solutions. Antonio Torres is a consultant for, and has received a grant from GT Metabolic Solutions. Marc Van Gossum, Jana Dziakova, Levan Koiava, Maja Odovic, and Mathilde Poras, have no potential conflicts of interest and nothing to disclose.
: The study was conducted in compliance with the registered Clinicaltrials.gov protocol (#NCT05322122) and in accord with the ethical standards of the institutional research committee, and with the 1964 Helsinki declaration and its later amendments, as well as with ISO14155 regulations, 21 CFR Parts 11, 50, 54, 56, and 812 Good Clinical Practices.
: Informed Consent was obtained with adequate understanding and consent of participating patients.